MWOIX
Price
$67.23
Change
-$1.70 (-2.47%)
Updated
Dec 18 closing price
RNPEX
Price
$64.62
Change
-$2.05 (-3.07%)
Updated
Dec 18 closing price
Ad is loading...

MWOIX vs RNPEX

Header iconMWOIX vs RNPEX Comparison
Open Charts MWOIX vs RNPEXBanner chart's image
MFS Global Growth I
Price$67.23
Change-$1.70 (-2.47%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R4
Price$64.62
Change-$2.05 (-3.07%)
VolumeN/A
CapitalizationN/A
MWOIX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MWOIX vs. RNPEX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MWOIX is a Buy and RNPEX is a Buy.

FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 149B vs. MWOIX (993M). RNPEX pays higher dividends than MWOIX: RNPEX (0.83) vs MWOIX (0.24). MWOIX was incepted earlier than RNPEX: MWOIX (28 years) vs RNPEX (23 years). MWOIX is a more actively managed with annual turnover of: 24.00 vs. RNPEX (17.00). MWOIX has a lower initial minimum investment than RNPEX: MWOIX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 23.10 vs. MWOIX (12.19). RNPEX (40.88) and MWOIX (38.94) have equivalent 5 years return.
MWOIXRNPEXMWOIX / RNPEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years23 years-
Gain YTD13.57721.48363%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets993M149B1%
Annual Yield % from dividends0.240.8330%
Returns for 1 year12.1923.1053%
Returns for 3 years8.637.22120%
Returns for 5 years38.9440.8895%
Returns for 10 years102.7676.05135%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHD105.80-0.02
-0.02%
Church & Dwight Co
BZH30.01-0.61
-1.99%
Beazer Homes USA
ESEA34.12-0.76
-2.18%
Euroseas Ltd
BHVN39.12-2.32
-5.60%
Biohaven Ltd
NXTC0.90-0.11
-10.82%
NextCure